LOAMS
Lombard Odier Asset Management (Switzerland) Portfolio holdings
AUM
$1.98B
This Quarter Return
+5.43%
1 Year Return
+25.93%
3 Year Return
+103.45%
5 Year Return
+160.5%
10 Year Return
+469.02%
AUM
$1.57B
AUM Growth
+$1.57B
(-2.7%)
Cap. Flow
-$30.3M
Cap. Flow
% of AUM
-1.93%
Top 10 Holdings %
Top 10 Hldgs %
22.89%
Holding
432
New
226
Increased
52
Reduced
94
Closed
41
Top Buys
| 1 |
CIXX
CI Financial Corp.
CIXX
|
$22.4M |
| 2 |
CRISPR Therapeutics
CRSP
|
$13.5M |
| 3 |
Virtus Investment Partners
VRTS
|
$11.9M |
| 4 |
Amazon
AMZN
|
$11.8M |
| 5 |
Medifast
MED
|
$11.5M |
Top Sells
| 1 |
Merck
MRK
|
$27.7M |
| 2 |
Voya Financial
VOYA
|
$24.9M |
| 3 |
Equity Lifestyle Properties
ELS
|
$23.4M |
| 4 |
BioNTech
BNTX
|
$16.1M |
| 5 |
iShares MSCI India ETF
INDA
|
$15.5M |
Sector Composition
| 1 | Healthcare | 52.77% |
| 2 | Consumer Discretionary | 15.05% |
| 3 | Financials | 13.41% |
| 4 | Technology | 7.21% |
| 5 | Industrials | 3.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
NeoGenomics
NEO
$1.15B
| $11.5M | 0.74% |
337,617
-246,664
| -42% | -$8.42M |
|
52
Quanterix
QTRX
$207M
| $11.4M | 0.73% |
269,062
+22,758
| +9% | +$965K |
|
|
GTHX
53
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
| $10.7M | 0.68% |
1,049,947
+88,808
| +9% | +$907K |
|
54
Karyopharm Therapeutics
KPTI
$58.6M
| $10.7M | 0.68% |
1,658,047
+140,243
| +9% | +$902K |
|
55
American Well
AMWL
$110M
| $10.1M | 0.65% |
1,674,678
+141,650
| +9% | +$856K |
|
56
Editas Medicine
EDIT
$227M
| $8.32M | 0.53% |
313,322
+104,818
| +50% | +$2.78M |
|
57
Sutro Biopharma
STRO
$80.1M
| $7.86M | 0.5% |
528,442
+44,679
| +9% | +$665K |
|
58
Alphabet (Google) Class C
GOOG
$2.55T
| $7.03M | 0.45% |
+2,431
| New | +$7.03M |
|
59
Tesla
TSLA
$1.06T
| $6.73M | 0.43% |
+6,372
| New | +$6.73M |
|
|
60
Alphabet (Google) Class A
GOOGL
$2.54T
| $6.71M | 0.43% |
+2,317
| New | +$6.71M |
|
61
Y-mAbs Therapeutics
YMAB
$389M
| $6.25M | 0.4% |
385,440
+32,601
| +9% | +$528K |
|
|
TRHC
62
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
| $5.92M | 0.38% |
394,559
+33,372
| +9% | +$501K |
|
63
Mercado Libre
MELI
$120B
| $5.91M | 0.38% |
+4,380
| New | +$5.91M |
|
64
Meta Platforms (Facebook)
META
$1.84T
| $5.81M | 0.37% |
17,266
-6,039
| -26% | -$2.03M |
|
65
Novavax
NVAX
$1.22B
| $5.56M | 0.36% |
38,881
-13,050
| -25% | -$1.87M |
|
66
NVIDIA
NVDA
$4.12T
| $5.29M | 0.34% |
17,969
-4,556
| -20% | -$1.34M |
|
|
SGFY
67
DELISTED
Signify Health, Inc.
SGFY
| $4.68M | 0.3% |
329,345
+27,857
| +9% | +$396K |
|
68
Adobe
ADBE
$146B
| $4.64M | 0.3% |
+8,184
| New | +$4.64M |
|
69
JPMorgan Chase
JPM
$821B
| $4.52M | 0.29% |
28,548
+1,317
| +5% | +$209K |
|
70
Nike
NKE
$110B
| $4.31M | 0.28% |
25,851
-2,118
| -8% | -$353K |
|
71
Salesforce
CRM
$240B
| $3.94M | 0.25% |
15,508
+658
| +4% | +$167K |
|
72
Korro Bio
KRRO
$197M
| $3.63M | 0.23% |
707,071
+59,806
| +9% | +$307K |
|
73
Estee Lauder
EL
$32.5B
| $3.58M | 0.23% |
+9,679
| New | +$3.58M |
|
74
Coca-Cola Europacific Partners
CCEP
$39.7B
| $3.35M | 0.21% |
59,961
+1,352
| +2% | +$75.6K |
|
75
Goldman Sachs
GS
$220B
| $3.16M | 0.2% |
+8,254
| New | +$3.16M |
|